the leukemia intergroup study has treated 110 patients with acute nonlymphocytic leukaemia with 'high dose ' cytosine arabinoside remission induction therapy and studied the factors which were related to the outcome of therapy .
C0023418
study
C0010711
cytosine arabinoside